StimAire is commercializing two neural stimulation technologies:
The first technology eliminates surgery for stimulating peripheral nerves up to 15 cm deep, replacing the pacemaker-like implants with an injectable and a wearable. This technology can eliminate the major surgery of existing therapies for Obstructive Sleep Apnea, Central Sleep Apnea, Bladder Incontinence, Rheumatoid Arthritis, Epilepsy, and Peripheral Pain.
The second technology eliminates the tingling (or “electric shock”) feeling, a side effect of TENS (transcutaneous electrical nerve stimulation) devices. Existing TENS devices require the user to increase the intensity to a barely tolerable level, severely limiting efficacy and acceptance. Our technology removes this side effect, increases the stimulation power, and can be applied to existing TENS devices for Migraine, Essential Tremor, Opioid Withdrawal, and many others.
StimAire is a venture-backed company.